Pharmaceuticals & Life Sciences Articles & Blogs

PING 2024 round-up - 'AI in pharma - Threat or opportunity?'

Tuesday, 16 July 2024

Over a month has passed since the 2024 PING conference, providing invaluable insights into the uptake of AI in Pharma, its transformational promise, and the accompanying risks and pitfalls. Below is a summary of our key takeaways.

PING 2024 round-up - 'AI in pharma - Threat or opportunity?'

Articles & Blogs Pharma & Life Sciences

23andMe Data Breach: strengthening defences and compliance in the life sciences industry

Tuesday, 16 July 2024

For life sciences companies processing health or genetic data, useful lessons can be taken from the 23andMe data breach, which is back in the spotlight thanks to a joint investigation by the UK and Canadian data protection authorities.

23andMe Data Breach: strengthening defences and compliance in the life sciences industry

News Pharma & Life Sciences

PING 2024 explores AI's transformative impact in pharma at annual Conference

Tuesday, 18 June 2024

VWV's PING (Pharmaceutical Industry Network Group) has celebrated 15 years of cutting-edge pharma conferences, this year focusing on the pressing issue of 'AI in pharma - Threat or opportunity?'.

PING 2024 explores AI's transformative impact in pharma at annual Conference

Articles & Blogs Pharma & Life Sciences

Medicines shortages have become commonplace since Brexit: Nuffield report

Wednesday, 22 May 2024

The number of warnings that pharma suppliers have given in the UK around medicine shortages have shot up from 648 in 2020 to 1,634 in 2023, causing serious problems for the NHS, doctors, pharmacists and patients.

Medicines shortages have become commonplace since Brexit: Nuffield report

Articles & Blogs Pharma & Life Sciences

AI - the MHRA's approach to the impending regulatory influx

Thursday, 16 May 2024

For UK Life Sciences, the MHRA shoulders the responsibility for balancing between making the UK a hub for AI innovation, and keeping products within acceptable limits. A likely rise in AI-related medical products also adds to the challenge.

AI - the MHRA's approach to the impending regulatory influx

Articles & Blogs Pharma & Life Sciences

BenevolentAI and AstraZeneca AI pharma collaboration yields success with heart failure target

Thursday, 16 May 2024

Using BenevolentAI's AI-driven drug discovery platform, the two companies have jointly identified a novel target for heart failure, which has been added to AstraZeneca’s discovery portfolio.

BenevolentAI and AstraZeneca AI pharma collaboration yields success with heart failure target

Articles & Blogs Pharma & Life Sciences

Patent licence drafting - top tips from recent case

Wednesday, 24 April 2024

A recent Court of Appeal case has provided important guidance for those drafting patent licences.

Patent licence drafting - top tips from recent case

Articles & Blogs Pharma & Life Sciences

MHRA responds to report on equity in medical devices

Wednesday, 24 April 2024

The independent report on equity in medical devices and the MHRA's response were published on 11 March 2024.

MHRA responds to report on equity in medical devices

Articles & Blogs Pharma & Life Sciences

Shadow Science Minister launches life sciences strategy in Stevenage visit

Tuesday, 16 April 2024

Members of the Labour Party, including the current Shadow Minister for Science, Peter Kyle, and Shadow Health Secretary, Wes Streeting, recently visited Stevenage Bioscience Catalyst to launch their Life Sciences Sector Plan.

Shadow Science Minister Launches Life Sciences Strategy in Stevenage Visit

Articles & Blogs Pharma & Life Sciences

Innovation and regulation - are they going to get the balance right for UK AI?

Thursday, 21 March 2024

In February this year, the UK Government published its response to a consultation on the regulation of AI. The essential question was: "How pro-innovation are we going to be here in the UK, and does that require new legislation?"

Innovation and regulation - are they going to get the balance right for UK AI?

Articles & Blogs Pharma & Life Sciences

Contracting for University research services - £100m claim leaves both sides dissatisfied

Thursday, 21 March 2024

In a recent case, a University was handed a £1m bill to pay and a pharmaceutical company was left with a stunted development programme - and all for a £50k pre-clinical study.

Contracting for University research services - £100m opportunity claim leaves both sides dissatisfied

Articles & Blogs Pharma & Life Sciences

More novel medicines drive faster global growth in next five years - IQVIA report

Thursday, 15 February 2024

Medicines use and global spending is going to be higher than previously thought in the five years to 2028, according to a report from IQVIA.

More novel medicines drive faster global growth in next five years - IQVIA report

Articles & Blogs Pharma & Life Sciences

A good companion for the long journey - companion diagnostics in the UK

Thursday, 15 February 2024

In the consultation concerning the reform of UK medical device regulation and the Government's published response to it, there are suggestions that the conspicuous absence of regulation and guidance on companion diagnostics will be fixed.

A good companion for the long journey - companion diagnostics in the UK

Articles & Blogs Pharma & Life Sciences

NHS extends Carbon Reduction Plan requirements from April 2024

Thursday, 15 February 2024

In October 2023, NHS England published important guidance on carbon reduction plans and net zero commitments in NHS procurements. NHS suppliers need to prepare for increasing attention on emissions reduction. It's not a 'nice to have'.

NHS extends Carbon Reduction Plan requirements from April 2024

Articles & Blogs Pharma & Life Sciences

New and updated UK clinical trial agreement templates published on IRAS

Monday, 22 January 2024

There is little room to negotiate the terms of these UK standard agreements, but sponsors should consider internal risk mitigation as part of the process.

New and updated UK clinical trial agreement templates published on IRAS

Pharma & Life Sciences

Share this page: